American Pacific's fine chemical division reported Q2 2012 sales of $20.6m up 28% from 2011 primarily due to strong revenues of anti-viral products. However, this was offset by lower oncology products revenues.
In-pharma Technologist
Tuesday, 15 May 2012
AmPac sales revenues rise in Q2
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment